Results from a meta-analysis of observational studies have lately shown an overall increased risk of cancer in patients treated with insulin, although a nonsignificant increased risk of breast cancer (RR 1.86; 95 % CI 0.92–2.98) was reported [32]. The gene discussed is INS; the disease is breast carcinoma.